Literature DB >> 15177542

Treatment of inflammatory bowel disease with antibiotics.

Kim L Isaacs1, R Balfour Sartor.   

Abstract

Although antibiotics are clearly recognized as having a role in treating the infectious complications of inflammatory bowel diseases (IBD), their impact in the primary treatment of IBD has long been an area of speculation. Over the past decade there is increasing evidence that luminal gut bacteria play a role in the pathogenesis of IBD, particularly Crohn's disease. Compelling evidence that normal commensal bacteria induce chronic intestinal inflammation in susceptible rodents provides an excellent rationale for treatment of human IBD with antibiotics. This article summarizes published studies of antibiotics in IBD patients and reviews available data for the use of antibiotic therapy in Crohn's disease and ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15177542     DOI: 10.1016/j.gtc.2004.02.006

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  12 in total

Review 1.  Antibiotic therapy for Crohn's disease: a review.

Authors:  Simon Lal; A Hillary Steinhart
Journal:  Can J Gastroenterol       Date:  2006-10       Impact factor: 3.522

2.  Crohn's disease as an immunodeficiency.

Authors:  Bu'Hussain Hayee; Farooq Z Rahman; Gavin Sewell; Andrew M Smith; Anthony W Segal
Journal:  Expert Rev Clin Immunol       Date:  2010-07       Impact factor: 4.473

Review 3.  Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate.

Authors:  Antonella Gallo; Giovanna Passaro; Antonio Gasbarrini; Raffaele Landolfi; Massimo Montalto
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

4.  The application of RNAi-based treatments for inflammatory bowel disease.

Authors:  Morten Tobias Jarlstad Olesen; Borja Ballarín-González; Kenneth Alan Howard
Journal:  Drug Deliv Transl Res       Date:  2014-02       Impact factor: 4.617

5.  Absence of bacterially induced RELMbeta reduces injury in the dextran sodium sulfate model of colitis.

Authors:  Laila D McVay; Sue A Keilbaugh; Tracie M H Wong; Sonja Kierstein; Marcus E Shin; Michael Lehrke; Martina I Lefterova; D Edward Shifflett; Sean L Barnes; Fabio Cominelli; Steven M Cohn; Gail Hecht; Mitchell A Lazar; Angela Haczku; Gary D Wu
Journal:  J Clin Invest       Date:  2006-10-05       Impact factor: 14.808

6.  The Role of Antibiotics in Inflammatory Bowel Disease.

Authors:  Chandrashekhar Thukral; Win J Travassos; Mark A Peppercorn
Journal:  Curr Treat Options Gastroenterol       Date:  2005-06

7.  A new animal model of postsurgical bowel inflammation and fibrosis: the effect of commensal microflora.

Authors:  R J Rigby; M R Hunt; B P Scull; J G Simmons; K E Speck; M A Helmrath; P K Lund
Journal:  Gut       Date:  2009-04-26       Impact factor: 23.059

Review 8.  Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era.

Authors:  Geoffrey A Preidis; James Versalovic
Journal:  Gastroenterology       Date:  2009-05       Impact factor: 22.682

9.  Orally administered extract from Prunella vulgaris attenuates spontaneous colitis in mdr1a(-/-) mice.

Authors:  Kelley Mk Haarberg; Meghan J Wymore Brand; Anne-Marie C Overstreet; Catherine C Hauck; Patricia A Murphy; Jesse M Hostetter; Amanda E Ramer-Tait; Michael J Wannemuehler
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-11-06

10.  A murine model of ulcerative colitis: induced with sinusitis-derived superantigen and food allergen.

Authors:  Ping-Chang Yang; Chang-Sheng Wang; Zi-Yuan An
Journal:  BMC Gastroenterol       Date:  2005-03-03       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.